Evidence map›Paper›PMID 38352132›Full record

ArticleFrontiers in public health2023

Ethnic and racial differences in self-reported symptoms, health status, activity level, and missed work at 3 and 6 months following SARS-CoV-2 infection.

Kelli N O'Laughlin, Robin E Klabbers, Imtiaz Ebna Mannan, Nicole L Gentile, Rachel E Geyer, Zihan Zheng, Huihui Yu, Shu-Xia Li, Kwun C G Chan, Erica S Spatz and 21 more

Abstract readMulticenter Study
In one paragraph

Article in Frontiers in public health, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Understanding how social determinants of health shape Long COVID outcomes: a rapid review of evidence.Archives of public health = Archives belges de sante publique · 2025
    Pooled it
  2. Article
  3. Article
  4. The Effect of SARS-CoV-2 Reinfection on Long-Term Symptoms in the Innovative Support for Patients With SARS-CoV-2 Infections Registry (INSPIRE).Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2025
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

31 authors.

Kelli N O'Laughlin *Department of Emergency Medicine, University of Washington, Seattle, WA, United States.
Robin E Klabbers *Department of Emergency Medicine, University of Washington, Seattle, WA, United States.
Imtiaz Ebna MannanCenter for Outcomes Research and Evaluation, Yale School of Medicine, New Haven, CT, United States.
Nicole L GentileDepartment of Family Medicine, University of Washington, Seattle, WA, United States.
Rachel E GeyerDepartment of Family Medicine, University of Washington, Seattle, WA, United States.
Zihan ZhengDepartment of Family Medicine, University of Washington, Seattle, WA, United States.
Huihui YuCenter for Outcomes Research and Evaluation, Yale School of Medicine, New Haven, CT, United States.
Shu-Xia LiCenter for Outcomes Research and Evaluation, Yale School of Medicine, New Haven, CT, United States.
Kwun C G ChanDepartment of Biostatistics, University of Washington, Seattle, WA, United States.
Erica S SpatzSection of Cardiovascular Medicine, Yale School of Medicine, New Haven, CT, United States.
Ralph C WangDepartment of Emergency Medicine, University of California San Francisco, San Francisco, CA, United States.
Michelle L'HommedieuDivision of General Internal Medicine and Health Services Research, David Geffen School of Medicine at UCLA, Los Angeles, CA, United States.
Robert A WeinsteinDivisions of Infectious Diseases, Department of Internal Medicine, Rush University Medical Center, Chicago, IL, United States.
Ian D PlumbNational Center for Immunizations and Respiratory Diseases, U.S. Centers for Disease Control and Prevention, Atlanta, GA, United States.
Michael GottliebDepartment of Emergency Medicine, Rush University Medical Center, Chicago, IL, United States.
Ryan M HuebingerUTHealth Houston McGovern Medical School Department of Emergency Medicine, Houston, TX, United States.
Melissa HagenNational Center for Immunizations and Respiratory Diseases, U.S. Centers for Disease Control and Prevention, Atlanta, GA, United States.
Joann G ElmoreDivision of General Internal Medicine and Health Services Research, David Geffen School of Medicine at UCLA, Los Angeles, CA, United States.
Mandy J HillUTHealth Houston McGovern Medical School Department of Emergency Medicine, Houston, TX, United States.
Morgan KellyDepartment of Emergency Medicine, Sidney Kimmel Medical College, Thomas Jefferson University, Philadelphia, PA, United States.
Samuel McDonaldDepartment of Emergency Medicine, University of Texas Southwestern Medical Center, Dallas, TX, United States.
Kristin L RisingDepartment of Emergency Medicine, Sidney Kimmel Medical College, Thomas Jefferson University, Philadelphia, PA, United States.
Robert M RodriguezDepartment of Emergency Medicine, University of California San Francisco, San Francisco, CA, United States.
Arjun VenkateshCenter for Outcomes Research and Evaluation, Yale School of Medicine, New Haven, CT, United States.
Ahamed H IdrisDepartment of Emergency Medicine, University of Texas Southwestern Medical Center, Dallas, TX, United States.
Michelle SantangeloDivisions of Infectious Diseases, Department of Internal Medicine, Rush University Medical Center, Chicago, IL, United States.
Katherine KooDivisions of Infectious Diseases, Department of Internal Medicine, Rush University Medical Center, Chicago, IL, United States.
Sharon SaydahNational Center for Immunizations and Respiratory Diseases, U.S. Centers for Disease Control and Prevention, Atlanta, GA, United States.
Graham Nichol *Department of Emergency Medicine, University of Washington, Seattle, WA, United States.
Kari A Stephens *Department of Family Medicine, University of Washington, Seattle, WA, United States.
INSPIRE Group

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Data on ethnic and racial differences in symptoms and health-related impacts following SARS-CoV-2 infection are limited. We aimed to estimate the ethnic and racial differences in symptoms and health-related impacts 3 and 6 months after the first SARS-CoV-2 infection. Methods: Participants included adults with SARS-CoV-2 infection enrolled in a prospective multicenter US study between 12/11/2020 and 7/4/2022 as the primary cohort of interest, as well as a SARS-CoV-2-negative cohort to account for non-SARS-CoV-2-infection impacts, who completed enrollment and 3-month surveys ( Results: Following SARS-CoV-2 infection, the majority of symptoms were similar over time between ethnic and racial groups. At 3 months, Hispanic participants were more likely than non-Hispanic participants to report fair/poor health (OR: 1.94; 95%CI: 1.36-2.78) and reduced activity (somewhat less, OR: 1.47; 95%CI: 1.06-2.02; much less, OR: 2.23; 95%CI: 1.38-3.61). At 6 months, differences by ethnicity were not present. At 3 months, Other/Multiple race participants were more likely than white participants to report fair/poor health (OR: 1.90; 95% CI: 1.25-2.88), reduced activity (somewhat less, OR: 1.72; 95%CI: 1.21-2.46; much less, OR: 2.08; 95%CI: 1.18-3.65). At 6 months, Asian participants were more likely than white participants to report fair/poor health (OR: 1.88; 95%CI: 1.13-3.12); Black participants reported more missed work (OR, 2.83; 95%CI: 1.60-5.00); and Other/Multiple race participants reported more fair/poor health (OR: 1.83; 95%CI: 1.10-3.05), reduced activity (somewhat less, OR: 1.60; 95%CI: 1.02-2.51; much less, OR: 2.49; 95%CI: 1.40-4.44), and more missed work (OR: 2.25; 95%CI: 1.27-3.98). Discussion: Awareness of ethnic and racial differences in outcomes following SARS-CoV-2 infection may inform clinical and public health efforts to advance health equity in long-term outcomes.

Indexed as

COVID-19AdultCOVID-19 VaccinesHealth StatusHumansProspective StudiesRace FactorsSARS-CoV-2Self ReportWhiteCOVID-19 VaccinescohortCOVID-19disparitiesethnicityraceSARS-CoV-2survey

Identifiers

PMID38352132
PMCPMC10861779

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.